Submit Deal

STALLERGENES GREER

Summary

Stallergenes Greer is a biopharmaceutical company which specializes in the diagnosis and treatment of allergies.

Deals Overview

Total Deals2

Valued Deals1

Total Value£ 104 M

Avg. Deal Size£ 104 M

Market Context

Senior Management

Michele Antonelli
CEO
Matthias A. Vogt
CFO
Stefan Meister
Chairman

Sort

fti consulting

HQ - Washington DC

pr advisors (1)

1 Shared Deal

1 For

£ 104 M

Total Value

havas

HQ - Paris

pr advisors (1)

1 Shared Deal

1 For

£ 104 M

Total Value

evercore

HQ - New York

financial advisors (2)

2 Shared Deals

1 For | 1 Opposite

£ 104 M

Total Value

clifford chance

HQ - London

legal advisors (1)

1 Shared Deal

1 For

£ 104 M

Total Value

jones day

HQ - Cleveland

legal advisors (1)

1 Shared Deal

1 For

£ 104 M

Total Value

finexsi

accounting advisors (1)

1 Shared Deal

1 For

£ 104 M

Total Value

ubs

HQ - Zurich

financial advisors (2)

2 Shared Deals

1 For | 1 Opposite

£ 104 M

Total Value

hirzel neef schmid konsulenten

pr advisors (1)

1 Shared Deal

1 Opposite

£ 104 M

Total Value

skadden arps slate meagher & flom

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 104 M

Total Value

mayer brown

HQ - Chicago

legal advisors (1)

1 Shared Deal

1 Opposite

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy